Diphtheria, Tetanus and Pertussis Clinical Trial
Official title:
Observational Post Authorisation Safety Study to Describe the Safety Profile of the Diphtheria, Tetanus, Acellular Pertussis Combination Vaccine, Reduced Antigen Content (Triaxis) as a 5th Dose in 4-6 Year Old Spanish Children
Primary objective: This is a descriptive study and the primary objective is to determine the incidence of injection site and systemic adverse events after Triaxis administration as a 5th dose of tetanus, diphtheria and acellular pertussis vaccine in 4-6 year old children
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01896596 -
Hepatitis B Vaccination in Infants
|
Phase 4 |